Oncolytics Biotech
ONCY
#9250
Rank
S$0.13 B
Marketcap
S$1.27
Share price
3.80%
Change (1 day)
7.38%
Change (1 year)

Earnings for Oncolytics Biotech (ONCY)

Earnings in 2025 (TTM): -S$32.68 Million

According to Oncolytics Biotech 's latest financial reports the company's current earnings are N/A. In 2024 the company made an earning of -S$33 Million a decrease over its 2023 earnings that were of -S$32.67 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Oncolytics Biotech from 2001 to 2025

Annual earnings

Year Earnings Change
2025 (TTM) -S$32.68 Million-0.95%
2024 -S$33 Million1.01%
2023 -S$32.67 Million23.39%
2022 -S$26.47 Million-1.98%
2021 -S$27.01 Million9.1%
2020 -S$24.76 Million22.64%
2019 -S$20.19 Million22.78%
2018 -S$16.44 Million4.1%
2017 -S$15.79 Million4.87%
2016 -S$15.06 Million8.75%
2015 -S$13.85 Million-37.06%
2014 -S$22 Million-26.2%
2013 -S$29.81 Million-37.39%
2012 -S$47.61 Million28.8%
2011 -S$36.96 Million46.02%
2010 -S$25.32 Million35.64%
2009 -S$18.67 Million-14.2%
2008 -S$21.75 Million-0.52%
2007 -S$21.87 Million24.6%
2006 -S$17.55 Million45.34%
2005 -S$12.08 Million-11.8%
2004 -S$13.69 Million115.36%
2003 -S$6.36 Million13.86%
2002 -S$5.59 Million-5.45%
2001 -S$5.91 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Aeterna Zentaris
AEZS
-S$7.12 Million-77.95%๐Ÿ‡บ๐Ÿ‡ธ USA
Eli Lilly
LLY
S$29.17 B-90,559.46%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
S$10.41 B-32,390.87%๐Ÿ‡บ๐Ÿ‡ธ USA
Teva Pharmaceutical Industries
TEVA
S$2.29 B-7,223.05%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel
AVEO Oncology
AVEO
-S$37.66 Million 16.73%๐Ÿ‡บ๐Ÿ‡ธ USA
Mirati Therapeutics
MRTX
-S$1 Billion 2,974.61%๐Ÿ‡บ๐Ÿ‡ธ USA